Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...
Initiating Phase 2b clinical trial in first half of 2025 after achieving a meaningful functional cure rate in cHBV patients treated with imdusiran and interferon WARMINSTER, Pa., Jan. 13, 2025 (GLOBE ...
Report Ocean has recently released its “Saudi Arabia Automotive Microcontrollers Market” Research Report for the years 2024-2032, presenting a comprehensive analysis of the market. This report ...